36 filings
8-K
FDMT
4D Molecular Therapeutics Inc
7 Jun 24
Entry into a Material Definitive Agreement
5:07pm
8-K
FDMT
4D Molecular Therapeutics Inc
24 May 24
Submission of Matters to a Vote of Security Holders
4:28pm
8-K
FDMT
4D Molecular Therapeutics Inc
9 May 24
4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
4:22pm
8-K
FDMT
4D Molecular Therapeutics Inc
29 Feb 24
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
4:12pm
8-K
FDMT
4D Molecular Therapeutics Inc
9 Feb 24
Other Events
4:56pm
8-K
b2esrjd7
4 Jan 24
Departure of Directors or Certain Officers
8:30am
8-K
vgb8m2msqsc4
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
xbuzk498ulrx nlah
9 Nov 23
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
4:23pm
8-K
go3vs hbdy1uuhd
12 Sep 23
Departure of Directors or Certain Officers
9:17pm
8-K
4l3ica8 yanzljm
9 Aug 23
4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results
4:26pm
8-K
4tpfpkb7pm7
10 Jul 23
Entry into a Material Definitive Agreement
9:31pm
8-K
4zpw4
25 May 23
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
9mb9ewky5n6
10 May 23
4D Molecular Therapeutics Reports First Quarter 2023 Financial Results
6:08pm
8-K
582ms0d a2
9 May 23
Other Events
4:43pm
8-K
7ims1uuf7d3dd
15 Mar 23
4D Molecular Therapeutics Reports Full Year 2022 Financial Results
4:15pm
8-K
7lx54wi
2 Feb 23
Other Events
7:08pm
8-K
6p3b0a77v7szjcxolgr
26 Jan 23
Other Events
4:50pm
8-K
cn6n5e8p1buw24v6yz
9 Nov 22
4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
4:08pm
8-K
gwcf87z046w
27 Sep 22
Departure of Directors or Certain Officers
4:25pm
8-K
7kz9nw3hiifrk60sy
11 Aug 22
4D Molecular Therapeutics Reports Second Quarter 2022 Financial Results and Provides 4D-310 Program Update
4:19pm